Comparative studies of the biological distinction between unipolar and bipolar depressions (Q41610016)

5 October 2017

1 reference

title

Comparative studies of the biological distinction between unipolar and bipolar depressions (English)

1 reference

5 October 2017

Yatham LN

1

1 reference

5 October 2017

Srisurapanont M

series ordinal

2

1 reference

5 October 2017

Zis AP

series ordinal

3

1 reference

5 October 2017

Kusumakar V

series ordinal

4

1 reference

5 October 2017

language of work or name

Englisch

0 references

publication date

1 January 1997

1 reference

5 October 2017

1 reference

5 October 2017

volume

61

1 reference

5 October 2017

issue

15

1 reference

5 October 2017

page(s)

1445-1455

1 reference

Research diagnostic criteria: rationale and reliability

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Reassessing the bipolar-unipolar dichotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Psychomotor activity in affective states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Behavioural measurement and drug response characteristics of unipolar and bipolar depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

The clinical picture of bipolar affective disorder in its depressed phase. A report from London and Chicago

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

The course of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Reliability and relationship of various ages of onset criteria for major affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

The significance of past mania or hypomania in the course and outcome of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

A prospective follow-up of patients with bipolar and primary unipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Lithium treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Course and outcome in bipolar affective disorder: a longitudinal follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Long-term stability of polarity distinctions in the affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Changes in urinary catecholamines and their metabolites in depressed patients treated with amitriptyline or imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

M.H.P.G. excretion and clinical classification in depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Urinary MHPG in subgroups of depressed patients and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Urinary MHPG, stress response, personality factors and somatosensory evoked potentials in normal subjects and patients with major affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Depressive symptom patterns and urinary MHPG excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Catecholamine metabolism and disposition in healthy and depressed subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Plasma norepinephrine level in affective disorders. Relationship to melancholia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Cerebrospinal fluid norepinephrine in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Platelet [3H]-imipramine binding according to DSM-III subtypes of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Altered platelet monoamine oxidase activity in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Platelet monoamine oxidase in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Monoamine oxidase activity in blood platelets from patients with cyclophrenic depressive syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Platelet monoamine oxidase activity in mental disorders: 2. Affective psychoses and suicidal behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Erythrocyte soluble catechol-O-methyl transferase activity in primary affective disorder. A clinical and genetic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Differential Catechol-O-Methyltransferase Activity in Unipolar and Bipolar Affective Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Plasma GABA in affective illness. A preliminary investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Plasma GABA levels in psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

CSF β-endorphin-immunoreactivity in normal, schiziphrenic, depressed, manic and anorexic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Cerebrospinal fluid somatostatin and psychiatric illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Elevated cerebrospinal fluid protein in men with unipolar or bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Memberane ATPase activities in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Calcium function in affective disorders and healthy controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Elevated platelet intracellular calcium concentration in bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Increased platelet intracellular calcium concentration in patients with bipolar affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

CSF magnesium in affective disorder: lack of correlation with clinical course of treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Growth-hormone and prolactin response to levodopa in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Growth hormone and prolactin response to levodopa in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Prolactin and growth hormone response to levodopa in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Hormonal responses during insulin-induced hypoglycemia in manic-depressed, unipolar depressed, and healthy control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Insulin tolerance test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Distinguishing unipolar and bipolar depression by thyrotropin release test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Thyrotropin-releasing-hormone test in unipolar and bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Distinguishing depression subtypes by thyrotropin response to TRH testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Thyrotrophin response to thyrotrophin-releasing hormone in unipolar and bipolar affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

High reverse T3 levels in manic an unipolar depressed women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

The dexamethasone suppression test: identification of subtypes of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

REM architecture changes in bipolar and unipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

All-night electroencephalographic sleep and cranial computed tomography in depression. A study of unipolar and bipolar patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Sleep parameters in bipolar I, bipolar II, and unipolar depressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Multivariate study of sleep EEG in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Reduction of prefrontal cortex glucose metabolism common to three types of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Long-latency auditory event-related potentials in schizophrenia and in bipolar and unipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Cerebral ventricular size in depressed subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Ventricular and sulcal size at the onset of psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Computed tomography in affective disorders. Part I. Ventricular and sulcal measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Ventricular abnormalities in affective disorder: clinical and demographic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Computed tomography in affective disorders. Part II. Brain density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Magnetic resonance imaging and mood disorders. Localization of white matter and other subcortical abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Treatment of acute bipolar depression: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Neuroendocrine evaluation of catecholaminergic neurotransmission in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

A family study of bipolar II disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Bipolar II illness: course and outcome over a five-year period.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

inferred from DOI database lookup

7 January 2021

based on heuristic

The course of affective disorders. I. Change of diagnosis of monopolar, unipolar, and bipolar illness

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Effects of age and gender on CNS serotonergic responsivity in normal adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

7 January 2021

Dopamine and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

MMPI measures of impulsivity and depression correlate with CSF 5-HIAA and HVA in depression but not schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

Cerebrospinal fluid correlates of suicide attempts and aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

CNS monoamine metabolism in bipolar affective disorder. Evaluation using a peripheral decarboxylase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

The reproducibility of the prolactin response to buspirone: relationship to the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900432-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(97)00432-3

1 reference

5 October 2017

1 reference